Insider trades
John F. Paolini, Chief Officer of Kiniksa Pharmaceuticals International KNSA, has filed 0 purchases and 24 sales on the open market. Over the past 12 months that comes to a net sale of $8M. The latest trade was on 05/01.
John F. Paolini
Chief Medical Officer
- First filing
- 23/03/20
- Trades
- 131 trades
- Buys / sales
- 0 / 24
- 12-month net buying
- −$8M
- Last trade
- 05/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
KNSA | Open-market sale10b5-1 plan | 05/01 | 05/05 | 58,424 sh2 trades | $53.71avg. | $3,137,822.92 | −47.1% |
KNSA | Open-market sale10b5-1 plan | 03/02 | 03/04 | 40,000 sh3 trades | $44.82avg. | $1,792,939.72 | −39.5% |
| Open-market sale10b5-1 plan | 25/10/31 | 25/11/04 | 82,542 sh | $37.14 | $3,065,609.88 | −57.4% | |
| Open-market sale10b5-1 plan | 25/08/06 | 25/08/08 | 29,325 sh | $32.55 | $954,528.75 | −33.8% | |
| Open-market sale10b5-1 plan | 25/05/07 | 25/05/09 | 200 sh | $27.00 | $5,400 | −0.3% | |
KNSA | Open-market sale10b5-1 plan | 24/09/03 | 24/09/04 | 60,692 sh2 trades | $26.12avg. | $1,584,991.4 | −53.8% |
KNSA | Open-market sale10b5-1 plan | 24/07/23 | 24/07/25 | 22,000 sh4 trades | $26.32avg. | $578,966.14 | −31.5% |
| Open-market sale10b5-1 plan | 24/03/01 | 24/03/05 | 18,844 sh | $21.77 | $410,233.88 | −29.6% | |
| Open-market sale10b5-1 plan | 24/02/27 | 24/02/29 | 10,156 sh | $21.03 | $213,580.68 | −18.4% | |
KNSA | Open-market sale10b5-1 plan | 23/12/07 | 23/12/11 | 28,600 sh4 trades | $17.65avg. | $504,758.39 | −38.9% |
| Open-market sale10b5-1 plan | 23/09/05 | 23/09/06 | 400 sh | $17.53 | $7,012 | −0.9% | |
KNSA | Open-market sale | 23/07/25 | 23/07/27 | 29,000 sh3 trades | $19.14avg. | $555,160.08 | −40.9% |